JY
INM icon

Jeff Yass’s InMed Pharmaceuticals INM Stock Holding History

Jeff Yass’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,753
Closed -$13.5K – 13604
2025
Q4 		$13.5K Buy
+12,753
New +$21.2K ﹤0.01% 12022
2023
Q4 		– Sell
-1,329
Closed -$18.3K – 12808
2023
Q3 		$18.3K Buy
1,329
+645
+94% +$11.8K ﹤0.01% 11623
2023
Q2 		$12.6K Sell
684
-257
-27% -$6.22K ﹤0.01% 11724
2023
Q1 		$20.3K Buy
+941
New +$30.4K ﹤0.01% 12047

Other funds holding INM

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $431M AUM 20.62% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Jeff Yass's INM Position: Q1 2026 in Review

Jeff Yass sold out of InMed Pharmaceuticals (INM) in Q1 2026, closing a stake of 12,753 shares — an estimated $13.5K sold.

Jeff Yass first reported a position in INM in Q1 2023 and held it in 4 quarters. The position peaked at $20.3K in Q1 2023. 9 funds tracked by Wall St. Rank hold INM as of Q1 2026.

  • Jeff Yass reported no remaining InMed Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 12,753 InMed Pharmaceuticals shares in Q1 2026, an estimated $13.5K.
  • Jeff Yass first reported a position in InMed Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • Jeff Yass's InMed Pharmaceuticals position peaked at $20.3K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.